A Sleeping Beauty mutagenesis screen reveals a tumor suppressor role for Ncoa2/Src-2 in liver cancer
Open Access
- 3 May 2012
- journal article
- research article
- Published by Proceedings of the National Academy of Sciences in Proceedings of the National Academy of Sciences of the United States of America
- Vol. 109 (21), E1377-E1386
- https://doi.org/10.1073/pnas.1115433109
Abstract
The Sleeping Beauty (SB) transposon mutagenesis system is a powerful tool that facilitates the discovery of mutations that accelerate tumorigenesis. In this study, we sought to identify mutations that cooperate with MYC, one of the most commonly dysregulated genes in human malignancy. We performed a forward genetic screen with a mouse model of MYC-induced liver cancer using SB-mediated mutagenesis. We sequenced insertions in 63 liver tumor nodules and identified at least 16 genes/loci that contribute to accelerated tumor development. RNAi-mediated knockdown in a liver progenitor cell line further validate three of these genes, Ncoa2/Src-2, Zfx, and Dtnb, as tumor suppressors in liver cancer. Moreover, deletion of Ncoa2/Src-2 in mice predisposes to diethylnitrosamine-induced liver tumorigenesis. These findings reveal genes and pathways that functionally restrain MYC-mediated liver tumorigenesis and therefore may provide targets for cancer therapy.This publication has 62 references indexed in Scilit:
- A Sleeping Beauty transposon-mediated screen identifies murine susceptibility genes for adenomatous polyposis coli ( Apc )-dependent intestinal tumorigenesisProceedings of the National Academy of Sciences of the United States of America, 2011
- Reprogramming the posttranslational code of SRC-3 confers a switch in mammalian systems biologyProceedings of the National Academy of Sciences of the United States of America, 2010
- Genome-wide mapping and assembly of structural variant breakpoints in the mouse genomeGenome Research, 2010
- A conditional transposon-based insertional mutagenesis screen for genes associated with mouse hepatocellular carcinomaNature Biotechnology, 2009
- An Oncogenomics-Based In Vivo RNAi Screen Identifies Tumor Suppressors in Liver CancerCell, 2008
- Zfx Controls the Self-Renewal of Embryonic and Hematopoietic Stem CellsCell, 2007
- Loss of hepatic NF-κB activity enhances chemical hepatocarcinogenesis through sustained c-Jun N-terminal kinase 1 activationProceedings of the National Academy of Sciences of the United States of America, 2006
- Identification and Validation of Oncogenes in Liver Cancer Using an Integrative Oncogenomic ApproachCell, 2006
- MYC inactivation uncovers pluripotent differentiation and tumour dormancy in hepatocellular cancerNature, 2004
- Targeting RAS signalling pathways in cancer therapyNature Reviews Cancer, 2003